No description available.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2016-07-15T12:20:21Z No. of bitstreams: 1 victoreustaquiotosteszidirich.pdf: 1142000 bytes, checksum: 2b246de219ef265a66f3c21f0381b817 (MD5) / Approved for entry into archive by Diamantino Mayra (mayra.diamantino@ufjf.edu.br) on 2016-07-19T15:50:40Z (GMT) No. of bitstreams: 1 victoreustaquiotosteszidirich.pdf: 1142000 bytes, checksum: 2b246de219ef265a66f3c21f0381b817 (MD5) / Made available in DSpace on 2016-07-19T15:50:40Z (GMT). No. of bitstreams: 1 victoreustaquiotosteszidirich.pdf: 1142000 bytes, checksum: 2b246de219ef265a66f3c21f0381b817 (MD5) Previous issue date: 2011-03-18 / O ácido linoléico conjugado, do inglês “Conjugated Linoleic Acid” (CLA) é uma mistura de isômeros de posição e geométricos do ácido linoléico (C18:2 n-6), comumente encontrado em maiores concentrações na carne bovina e em produtos lácteos de ruminantes. Numerosas atividades biológicas têm sido atribuídas aos isômeros C18:2 cis-9, trans-11(c9t11) e ao C18:2 trans-10, cis-12 (t10c12) dentre as quais destacam-se: propriedades anticarcinogênica, antiaterogênica, antiobesogênica, incluindo aumento da massa magra em animais, retardo do aparecimento de diabetes tipo II e também nas respostas imunes humoral e celular. O presente trabalho focou na utilização do c9t11 na dieta em camundongos da linhagem BALB/c, avaliando efeitos na resposta imune humoral como a produção anticorpos específicos para ovalbumina (OVA), bem como a síntese de citocinas e respostas à hipersensibilidade tardia (HTT). O trabalho mostrou que o CLA na dieta reduziu efeitos nas respostas de HTT em 24 horas nos animais e estes apresentaram altos níveis de Ac anti- IgG1 e supressão no perfil Th1 de citocinas como IFN-γ e TNF-α. Com base nesses resultados foi possível perceber que o CLA foi um importante fator no controle do processo inflamatório do modelo e que seu uso poderia ser considerado como uma importante intervenção profilática para muitas doenças de natureza inflamatória. / Conjugated Linoleic Acid (CLA) is a mixture of positional and geometrical isomers of linoleic acid (C18:2 n-6), commonly found in high concentrations in bovine meat and lacteous products from ruminants. Numerous biological activities have been attributed to C18:2 cis-9, trans-11(c9t11) and C18:2 trans-10, cis-12 (t10c12) isomers, among which anti-carcinogenic, anti-aterogenic, anti-obesity properties must be highlighted, including increase of thin mass in animals, delay in type II diabetes emergence and also in humoral and cellular immune responses. This work focused on the use of c9t11 in the diet of BALB/c mice, evaluating effects on humoral immune response by means of production of ovalbumin (OVA) specific antibodies, cytokine production and responses to delayed type hypersensitivity (DTH). The results showed that using CLA in the diet of BALB/c mice decreased effects on DTH responses in a 24h period after animals had been challenged. They exhibited high levels of Ab anti-IgG1 and suppression of Th1 profile cytokines such as IFN-γ and TNF-α. Based on these results, it was possible to say that CLA was an important factor of control in the inflammatory process of the model and that its use could be considered as an important prophylactic intervention for many diseases of inflammatory nature.

Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Objective: To investigate the relation of HPA responsiveness and serotonin transporter (5-HTT) availability in otherwise healthy individuals with obesity class II or III (OB) compared to non-obesity controls (NO). Study participants: Twenty-eight OB (21 females; age 36.6 10.6 years; body mass index (BMI) 41.2 5.1 kg/m2) were compared to 12 healthy NO (8 females; age 35.8 7.4 years; BMI 22.4 2.3 kg/m2), matched for age and sex. Methods: HPA axis responsiveness was investigated using the combined dexamethasone/corticotropin-releasing hormone (dex/CRH) test, and curve indicators were derived for cortisol and adrenocorticotropic hormone (ACTH). The 5-HTT selective tracer [11C]DASB was applied, and parametric images of the binding potentials (BPND) were calculated using the multilinear reference tissue model and evaluated by atlas-based volume of interest (VOI) analysis. The self-questionnaires of behavioral inhibition system/behavioral activation system (BIS/BAS) with subscales drive, fun-seeking and reward were assessed. Results: OB showed significant positive correlations of ACTH curve parameters with overall 5-HTT BPND (ACTHAUC: r = 0.39, p = 0.04) and 5-HTT BPND of the caudate nucleus (ACTHAUC: r = 0.54, p = 0.003). In NO, cortisol indicators correlated significantly with BPND in the hippocampus (cortisolAUC: r = 0.59, p = 0.04). In OB, BAS reward was inversely associated with the ACTHAUC (r = 0.49, p = 0.009). Conclusion: The present study supports a serotonergic-neuroendocrine association, which regionally differs between OB and NO. In OB, areas processing emotion and reward seem to be in-volved. The finding of a serotonergic HPA correlation may have implications for other diseases with dysregulated stress axis responsiveness, and for potential pharmacologic interven-tions.

Los trastornos emocionales de tipo depresivo y la ansiedad son las formas más prevalentes de enfermedad mental y suponen un serio problema de salud en la sociedad occidental. Recientemente, se ha postulado que el sistema endocannabinoide pueda ser un importante sustrato en el desarrollo de estos trastornos dada su participación en el control de las emociones. Nuestros resultados demuestran que los animales carentes del receptor cannabinoide CB1 manifiestan un fenotipo de tipo depresivo asociado a una deficiencia del factor neurotrófico BDNF en el hipocampo, que podría estar causada por los elevados niveles de glucocorticoides liberados en respuesta al estrés en estos mutantes. Por otra parte, el sistema endocannabinoide participa en los efectos inducidos por la nicotina sobre la ansiedad y en la expresión del síndrome de abstinencia de esta droga. Así, la actividad del receptor CB1 alivia los efectos ansiogénicos de dosis elevadas de nicotina y facilita los efectos ansiolíticos de dosis bajas. Además, la administración del agonista cannabinoide 9-THC atenúa las manifestaciones somáticas y emocionales negativas de la abstinencia de nicotina. En general, considerando los resultados presentados en esta Tesis Doctoral, podemos afirmar que el receptor CB1 participa de forma determinante en la recuperación del balance homeostático del organismo tras la exposición a un estímulo emocional negativo, bien sea una situación estresante aguda o sostenida, o bien una droga que incrementa los niveles de ansiedad o cuya retirada produce abstinencia. / Mood disorders such as depression and anxiety are the most common mental diseases and they suppose a serious health problem in our society. Recently, endocannabinoid system has been postulated to be an important substrate in the development of such disorders taking into account the role exerted by this neuromodulatory system in mood and emotions. Our results demonstrate that CB1 knockout mice exhibit a depressive-like phenotype associated to a deficiency in the neurotrophic factor BDNF in the hippocampus, which could be a consequence of the increased glucocorticoid release in response to stress exposure. On the other hand, the endocannabinoid system participates in nicotine induced effects on anxiety and in the expression of nicotine withdrawal. Thus, CB1 receptor activity attenuates anxiogenic-like effects and facilitates anxiolytic-like responses induced by high or low doses of nicotine, respectively. Moreover, 9-THC administration ameliorates somatic and negative motivational signs of nicotine withdrawal. In summary, the results presented in this Doctoral Thesis indicate that CB1 receptor participates in the recovery of the homeostatic balance after the exposure to negative emotional stimuli, either acute or sustained stress or a drug which induced anxiety-like effects or withdrawal signs after the end of the exposure.